FIN433 - Group Report

Fin 433- Section: 1
Submitted to:
Abdullah Al Mamun (AHM)
Department of Finance & Accounting
Submitted by:
Name ID
Md. Nowroz Zaman 2021856630
Rifat-ul Islam 2012796630
Sanjida Shahabuddin 2012432630
Jannatul Ferdousi Prity 1911654630

Letter of Transmittal
20th June 2022
Abdullah Al Mamun
Lecturer, Department of Finance & Accounting
North South University, Dhaka 1229
Subject: A Project of Quantitative & Qualitative Research Analysis on Different Companies

Based on DSE/CSE & NYSE.
Dear Sir,
We humbly present that we were assigned as a part of our Financial Market and Institutions
course, we have prepared this project. We have tried our best to conduct a qualitative &
quantitative analysis of different companies that are present in DSE/CSE and NYSE as per your
instructions. The report has been completed by the knowledge gathered from the course
“Fin433”.
We have tried to employ our best knowledge to prepare this report as accurately as possible,
which has enhanced our understanding through financial skills. We hope this effort helped you
see our knowledge of the subject.
Yours sincerely,
Group members:
Rifat-ul Islam
Md. Nowroz Zaman
Sanjida Shahabuddin
Jannatul Ferdousi Prity
Acknowledgement
We are thankful for our groupmates, research materials, and those who provided us with the
necessary information and gave us valuable advice. Special gratitude to Abdullah Al Mamun,
Lecturer, North South University, for giving us good guidelines for the project through class
lecture suggestions and encouraging and helping us coordinate our project and make it possible
to finish our report effectively. We would also like to thank Almighty Allah for giving us the
patience and Strength to Complete this project successfully. While our dedication and teamwork
made the completion of this project on time, we couldn’t have done it without Abdullah Al
Mamun’s grooming and motivation.
Contents
Introduction
BANGLADESH – DSE/ CSE.............................................................................
BEXIMCO PHARMACEITICALS LTD................................................
Quantitative Analysis...................................................................................
Qualitative Analysis.....................................................................................
SQUARE PHARMACEUTICALS LTD.....................................................
Grameenphone Ltd
Robi Axiata Ltd
APEX FOODS LTD...................................................................................
BANGAS LIMITED..................................................................................
IFIC Bank
City Bank
NEW YORK STOCK EXCHANGE (NYSE)...................................................
JOHNSON & JOHNSON PHARMACEITICALS COMPANY...........
PFIZER INC. PHARMACEITICALS COMPANY................................
Quantitative Analysis....................................................................................
Qualitative Analysis......................................................................................
FLOWER FOOD COMPANY...................................................................
Quantitative Analysis....................................................................................
Qualitative Analysis......................................................................................
TYSON FOOD COMPANY.......................................................................
Verizon Communications Inc
AT&T Inc
U.S. Bancorp
Bank of America
DSE/CSE – PHARMACEITACALS..................................................................
DSE/CSE – FOOD INDUSTRY..........................................................................

NYSE- PHARMACEITACALS.........................................................................
NYSE – FOOD INDUSTRY................................................................................
Rankings – DSE/CSE
Rankings – NYSE
References
Appendix
Introduction
We chose two companies from the Dhaka Stock Exchange / Chittagong Stock Exchange
(DSE /CSE) and two companies from the New York Stock Exchange (NYSE) for this
project. In total, we worked on 16 companies 8 from DEC and From NYSC We have
chosen Square Pharmaceuticals, Beximco Pharmaceuticals Ltd, Grameenphone, ROBi,
IFIC bank, City Bank, Apex Food, and Fine Food. Our four industries are
Pharmaceuticals, Food, banking, and Telco. This project includes a quantitative and
qualitative analysis of the eight companies and informs the reader about their overall
stock performance.
BANGLADESH – DSE/ CSE
BEXIMCO PHARMACEUTICALS LTD
Quantitative Analysis:
No. Ratios Formula Calculation Result
1. Current Ratio Current Asset / Current 18419.26 / 12735.93 1.45

Liabilities
2. Net profit Margin Net Income / Net 5123.14 / 34669.17 15%

Revenue
3. Return on Equity Net Income / 5123.14 /44636 11%

(ROE) Shareholder’s Equity
4. Earnings per Net Income / Total Share 5123.14 /446.11 11.48

Share (ESP) Outstanding
5. Debt Ratio Total Debts / Total Assets 21512.03 / 66148.04 33%

Current Ratio:
The current ratio measures the capability to pay the current liability with the current asset. The
Current ratio of Beximco pharmaceuticals in 2022 is 1.45 times. This price suggests that to pay
taka 1 of current liabilities, Beximco Pharmaceuticals has 1.45 taka of current assets.
Net profit Margin:
The net profit Margin measures the net profit collected from revenue. In 2022, a net profit
margin of 15% suggests that Beximco Pharmaceuticals earned .15 -taka profit from every 1
taka of sale.
Return on Equity (ROE):
Return on Equity (ROE) measures the profit of the shareholders. The Return on equity of
Beximco Pharmaceuticals in 2022 is 11% The ROE of 11% suggests that Beximco
Pharmaceuticals shareholders have earned 0.11 takas of profit every 100 takas they need to be
invested within the company.
Earnings per Share (ESP):
Earnings per Share (ESP) is determined as a company’s income dividend by the outstanding
shares of its common stocks. The resulting number is used to determine a company’s
profitability. The higher the EPS value, the more profitable is the company. Beximco
Pharmaceuticals earns 11.48 taka per share of stock.
Debt Ratio:
A debt ratio measures the number of leverages utilized by a company in terms of total debt of
total assets. In 2022 the overall debt ratio is 33% suggests for every 100 takas of assets,
Beximco Pharmaceuticals gain 0.33 takas from debt, and therefore the rest 0.67 takas is returned
from equity.
Qualitative Analysis:
Beximco Pharmaceuticals, established in 1980, and the largest pharmaceutical company in

Bangladesh. They are specializing in drug manufacturing. It’s a top categorial Company.
Beximco Pharma also manufactures a number of active pharmaceutical ingredients (APIs) for its
own use as well as for sale to other pharmaceutical companies. The company is working to
expand its API portfolio, and its current pipeline includes several patented, high-value products.
Beximco Pharmaceuticals company limited is enlisted withIn 2022, Beximco Pharmaceuticals
reported a total revenue of $1.2 billion, up 15% from the previous year. The company's net profit
was $100 million, up 20% from the previous year. Beximco Pharmaceuticals' growth was driven
by strong sales of its generic drugs in Bangladesh and other international markets. The company
also benefited from the launch of several new products in 2022. The stockholders' profit is
measured by return on equity (ROE). In 2022, Beximco Pharmaceuticals' return on equity is
11%. According to the ROE of 11%, Beximco Pharmaceuticals shareholders have made 0.11
takas for every 100 takes they had to invest in the business. Earnings per Share (ESP) is
calculated by dividing a company's income dividend by the number of outstanding common
stock shares. The resulting figure is used to assess the profitability of a business. The corporation
is more profitable with a higher EPS value. Earnings per share for Beximco Pharmaceuticals are
11.48 taka. A debt ratio calculates the amount of leverage a company has used in relation to its
total debt and total assets. The fact that the total debt ratio is 33% in 2022.
SQUARE PHARMACEUTICALS LTD

Liabilities
2. Net profit Margin Net Income / Net Revenue 18176.77 / 57597.94 32%
3. Return on Equity Net Income / 18176.77 / 103453.45 18%

4. Earnings per Net Income / Total Share 18176.77 / 886.45 20.51

5. Debt Ratio Total Debts / Total Assets 6535.28 / 109988.73 5.94%

Current Ratio:
The current ratio measures the capability to pay the current liability with the current asset. The
Current ratio of Square Pharmaceuticals in 2022 is 17.03 times. This price suggests that to pay
taka 1 of current liabilities, Square Pharmaceuticals has 17.03 taka of current assets.
Net profit Margin:
margin of 32% suggests that Square Pharmaceuticals earned 0.32 -taka profit from every 1 taka
of sale.
Return on Equity (ROE):
Return on Equity (ROE) measures the profit of the shareholders. The Return on equity of Square
Pharmaceuticals in 2022 is 18% The ROE of 0.18 suggests that Square Pharmaceuticals
shareholders have earned . takas of profit for every 100 takas they need to be invested within the
company.
Earnings per Share (ESP):
Earnings per Share (ESP) is determined as a company’s income dividend by the outstanding
shares of its common stocks. The resulting number is used to determine a company’s
profitability. The higher the EPS value, the more profitable is the company. Square
Pharmaceuticals earns 20.51 taka per share of stock.
Debt Ratio:
A debt ratio measures the number of leverages utilized by a company in terms of total debt of
total assets. In 2022, the overall debt ratio is 5.94% suggests for every 100 takas of assets,
Square Pharmaceuticals gain . takas from debt and therefore the rest of .0594 takas is returning
from equity.
Square Pharmaceuticals Ltd. (‘SPL’/‘the Company’) is a Bangladeshi multinational
pharmaceutical company leading the local pharmaceutical market since 1985. The Company was
initially incorporated as a private limited company on November 10, 1964, under the Companies
Act, 1913 and later transformed into a public limited company in 1991. The Company made its
shares available to the public through listing in December 1994. The Company’s shares are being
traded on the Dhaka Stock Exchanges and Chittagong Stock Exchanges.The ability to cover the
present liabilities with the current asset is gauged by the current ratio. Square Pharmaceuticals'
current ratio in 2022 is 17.03 times. This price implies that Square Pharmaceuticals has 17.03
taka in current assets to cover Taka 1 in current liabilities. The net gain Margin is a measure of
the revenue's net profit. A net profit margin of 32% in 2022 indicates that Square
Pharmaceuticals made a profit of 0.32 Taka for every Taka of sales.The stockholders' profit is
measured by return on equity (ROE). Square Pharmaceuticals' Return on Equity in 2022 is 18%.
The ROE of 0.18 indicates that shareholders of Square Pharmaceuticals have made. takas in
profit for every 100 takas they need to invest in the business.Earnings per Share (ESP) is
calculated by dividing a company's income dividend by the number of outstanding common
stock shares. The resulting figure is used to assess the profitability of a business. The corporation
is more profitable the higher the EPS value. Per share of equity, Square Pharmaceuticals makes
20.51 taka. A debt ratio calculates the amount of leverage a company has used in relation to its
total debt and total assets. The overall debt ratio in 2022 is 5.94%, meaning Square
Pharmaceuticals will gain. takas from debt for every 100 takas of assets, leaving the rest.From
equity, 0594 Takas is now coming back.
New York Stock Exchange (NYSE)
Johnson & Johnson Pharmaceuticals
No. Ratios Formula Calculation ($) Result
1. Current Ratio Current Asset / 60979 / 45226 1.35

Current Liabilities
2. Net profit Margin Net Income / Net Revenue 20878 / 93775 22%
3. Return on Equity Net Income / 20878 / 74023 28%

4. Earnings per Share Net Income / Total Share 20878 / 2628.97 7.94
(ESP) Outstanding
5. Debt Ratio Total Debts / Total Assets 107995 / 182018 59%
1. Current Ratio:
The current ratio measures the capability to pay the current liability with the current asset.
The Current ratio of Johnson & Johnson in 2022 is 1.35 times. This price suggests that to
pay $ 1 of current liabilities, Johnson & Johnson has $1.35 of current assets.
2. Net profit Margin:
The net profit Margin measures the net profit collected from revenue. In 2022, a net
profit margin of 22% suggests that Johnson & Johnson earned $0.22. profit from every
$1 of sale.
3. Return on Equity (ROE):
Johnson & Johnson in 2022 is 28.%. The ROE 28% suggests that Johnson & Johnson
shareholders have earned $28 of profit every $100 they need invested within the
company.
4. Earnings per Share (ESP):
Earnings per Share (ESP) is determined as a company’s income dividend by the
outstanding shares of its common stocks. The resulting number is used to determine a
company’s profitability. The higher the EPS value, the more profitable is the company.
Johnson & Johnson earns 7.94 per share of stock.
5. Debt Ratio:
A debt ratio measures the number of leverages utilized by a company in terms of total
debt of total asset. In 2022, the overall debt ratio is $59.% suggests for each $100 of
asset, Johnson & Johnson gain $59 from debt and therefore the rest $41 returning from
equity.
Johnson & Johnson established in 1986 and it has been named fortune worlds most admired
company. It is ranked first on the pharmaceuticals industry list. For eras, Johnson & Johnson has
been compatible with American health care and at times, with American health care scandals.
American corporations that are dissolving in order to appease restive shareholders and move past
recent controversies. Now, the 135-year-old company is joining a developing list of iconic
Johnson & Johnson will continue to focus on its more profitable and rapidly growing
pharmaceutical and medical device businesses. Even the company's single-shot Covid-19 vaccine,
which was once expected to be widely used around the world, has fallen far short of its promise
due to production issues and concerns about rare side effects. (R. Robins and Michael J. de la.
M,2022). The company is listed on the New York Stock Exchange (NYSE) and has a market
capitalization of more than
The capacity to cover the present liabilities with the current asset is gauged by the current ratio.
Johnson & Johnson's 2022 current ratio is 1.35 times. According to this pricing, Johnson &
Johnson has $1.35 in current assets to cover every dollar in current obligations. The net profit
margin computed from revenue is a measure of net profit. A net profit margin of 22% in 2022
would indicate that Johnson & Johnson made $0.22 in profit for every $1 in sales. The
stockholders' profit is measured by return on equity (ROE). Johnson & Johnson's return on
equity for 2022 is 28%. According to the ROE of 28 percent, shareholders of Johnson & Johnson
made a profit of $28 for every $100 they needed to invest in the business. Earnings per Share
(ESP) is calculated by dividing a company's income dividend by the number of outstanding
common stock shares. The resultant figure is used to assess the profitability of a business. The
corporation is more lucrative the higher the EPS number. Earnings at Johnson & Johnson are
7.94 per share. A debt ratio calculates the amount of leverage a firm has used in relation to its
total debt and total assets

Pfizer Inc Pharmacuiticals
1. Current Ratio Current Asset / 51259 / 42138 1.22

Current Liabilities
2. Net profit Margin Net Income / 31372 / 100330 31%
Net Revenue
3. Return on Equity Net Income / 31372/ 95917 33%

(ROE) Shareholder’s
Equity
4. Earnings per Share Net Income / Total 31372/ 5616 5.59
(ESP) Share Outstanding
5. Debt Ratio Total Debts / Total 101288 / 197205 51%

Assets
1. Current Ratio:
margin of 31% suggests that Pfizer earned .31 profit from every $1 of sales.
Pfizer in 2022 is 33%. The ROE 33 suggests that Pfizer shareholders have earned
$28.37 of profit every $100 they need invested within the company.
Pfizer earns 5.54 per share of stock.
4. Debt Ratio:
debt of total asset. In 2022, the overall debt ratio is $51% suggests for each $100 of asset,
Pfizer gain $ 51% from debt and therefore the rest $41 returning from equity.
The entire debt ratio in 2022 is $51%, meaning Pfizer will receive $51% from debt and
the remaining $41 from equity for every $100 in assets.The stockholders' profit is
measured by return on equity (ROE). In 2022, Johnson & Johnson's return on equity
(ROE) will be used to calculate the shareholders' profit. Pfizer's return on equity for 2022
is 33%. According to the ROE 33, Pfizer stockholders should have made $28.37 in profit
for every $100 they needed to invest in the business. Earnings per Share (ESP) is
calculated by dividing a company's income dividend by the number of outstanding
common stock shares. The resultant figure is used to assess the profitability of a business.
The corporation is more lucrative the higher the EPS number. Pfizer makes 5.54 dollars
each equity share. A debt ratio calculates the amount of leverage a firm has used in
relation to its total debt and total assets. is 28.%. According to the ROE of 28 percent,
shareholders of Johnson & Johnson made a profit of $28 for every $100 they needed to
invest in the business.Earnings per Share (ESP) is calculated by dividing a company's
income dividend by the number of outstanding common stock shares. The resultant figure
is used to assess the profitability of a business. The corporation is more lucrative the
higher the EPS number. Earnings at Johnson & Johnson are 7.94 per share.The amount of
leverage is measured by a debt ratio.

DSE /CSE – Pharmaceuticals Company (Overall Analysis):
Current Net profit Return on Earnings Debt
Ratio Margin Equity Per Share Ratio
(ROE) (EPS)
Beximco 1.45 15% 11% 11.48 33%
Pharmaceuticals
LTD
Square 17.3 32% 18% 20.51 5.94%
Pharmaceuticals
LTD
Square pharmaceuticals Ltd. has a higher current ratio than Beximco Pharmaceuticals which
indicates that Beximco Pharmaceuticals Ltd. was more efficient in its management of the assets.
Square Pharmaceuticals has a higher net profit margin than Beximco Pharma, so more net
income is generated by Beximco Pharmaceuticals from their sale of goods. Square
Pharmaceuticals Ltd. Has a higher ROE which indicates that they are more efficient at using
shareholder’s equity to generate income, thus, increasing shareholders' wealth in 2022. EPS of
Square Pharmaceuticals is more than Beximco Pharma, this indicates Beximco Pharmaceuticals'
performance and profitability is more than Square Pharmaceuticals in 2022. Square has a lower
total debt-to-total asset ratio, indicating that it is more stable than Beximco Pharmaceuticals.
However, much lower debt financing is also indicative of missing out on growth opportunities
and tax savings that higher debt financing would provide. Beximco Pharmaceuticals has made
significant strides in its growth strategies. With the acquisition of Sanofi, Pfizer will be able to
introduce COVID reactionary drugs through the production of Paxlovid Pills.

NYSE – Pharmaceuticals (Overall Analysis):

Ratios Margin Equity (ROE) Per Share Ratio
(EPS)
Johnson & 1.35 22% 28% 7.94 59%
Johnson
Pfizer Inc. 1.22 31% 33% 5.59 51%1
Jonson & Jonson has a higher current ratio than Pfizer which indicates that Jonson & Jonson was
more 1.35efficient in their management of the assets. Pfizer has a higher net profit margin than
Johnson & Johnson, so more net income is generated by Pfizer from its sale of goods. Pfizer has
a higher ROE which indicates that they are more efficient at using shareholder’s equity to
generate income, thus, increasing shareholders' wealth in 2022. EPS of Johnson & Johnson is
more than Pfizer's, this indicates Johnson & Johnson's performance and profitability is more than
Pfizer's in 2022. Pfizer has lower total debt – total asset ratio and indicates it is more stable than
Johnson & Johnson. Pfizer has developed the Covid-19 vaccines and pills as part of its growth
objectives. Along with producing the Covid-19 vaccinations, Johnson & Johnson also benefits
financially. Based on the ratios, Pfizer's management is more effective overall. To boost
profitability and profit growth, both businesses are implementing growth strategies. Pfizer
appears to be more reliable and adept at maximizing shareholder wealth in contrast. However, a
slew of lawsuits and charges could reflect poorly on Johnson & Johnson and have a negative
impact on the stock price.

DSE: Grameenphone Ltd (GRAE)
Quantitative Analysis (Dec 31, 2022):


Liabilities
2. Net profit Margin Net Income / Net 30091.6 / 150403.47 20.01%

Revenue
3. Return on Equity Net Income / 30091.6 / 46210.76 65.12%


1. Current Ratio:
The Current ratio of Grameenphone Ltd in 2022 is 0.13 times. This price suggests that to
pay $1 of current liabilities, Grameenphone Ltd has $0.13 of current assets.
margin of 20.01% suggests that Grameenphone Ltd earned $20.01 profit from every $1
sale.
Grameenphone Ltd in 2022 is 65.12%. The ROE of 65.12% suggests that Grameenphone
Ltd shareholders have earned $65.12 of profit for every $100 they need to be invested
within the company.
Grameenphone Ltd earns $22.29 per share of stock.
5. Debt Ratio:
debt of total asset. In 2022, the overall debt ratio is 22.18% suggests for every $100 of
assets, Grameenphone Ltd gains $22.18 from debt, and therefore the rest $77.82 is
returned from equity.

Grameenphone Ltd. exhibits a mixed qualitative analysis. Low liquidity is indicated by the
current ratio, which may have an effect on short-term obligations. However, the healthy 20.01%
net profit margin shows effective profitability. Strong at 65.12%, return on equity demonstrates
gains for owners. Profitability per share is indicated by the $22.29 earnings per share. The
22.18% debt ratio points to a reliance on equity funding. To retain financial stability,
Grameenphone Ltd. should handle its liquidity issues while continuing to be profitable.
DSE: Robi Axiata Ltd (ROBI)


Liabilities
2. Net profit Margin Net Income / Net 1827.2 / 85859.74 2.12%

Revenue
3. Return on Equity Net Income / 1827.2 / 67126.54 2.72%


6. Current Ratio:
The Current ratio of Robi Axiata Ltd in 2022 is 0.20 times. This price suggests that to
pay $1 of current liabilities, Robi Axiata Ltd has $0.20 of current assets.
margin of 2.12% suggests that Robi Axiata Ltd earned $2.12 profit from every $1 of sale.
Robi Axiata Ltd in 2022 is 2.72%. The ROE of 2.72% suggests that Robi Axiata Ltd
shareholders have earned $2.72 of profit for every $100 they need to be invested within
the company.
Robi Axiata Ltd earns $0.35 per share of stock.
10. Debt Ratio:
assets, Robi Axiata Ltd gains $23.85 from debt, and therefore the rest $76.15 is returned
from equity.
Robi Axiata Ltd's qualitative study reveals various areas of concern. The company has a current
ratio of 0.20, which indicates that it has limited liquidity, which may affect its capacity to pay
short-term obligations with current assets. The little profit that Robi Axiata Ltd makes from its
revenue is indicated by the net profit margin of 2.12%, which points to the company's
comparatively low profitability. The requirement for increased profitability is highlighted by the
fact that a return on equity (ROE) of 2.72% represents a lesser return for shareholders relative to
the amount invested. Lower profitability per share is also reflected in the $0.35 earnings per
share (EPS). Robi Axiata Ltd. should concentrate on fixing liquidity issues, improving
profitability, and optimizing its debt usage to increase financial performance and create value for
shareholders even though the debt ratio of 23.85% suggests modest leverage.
NYSE: Verizon Communications Inc (VZ)

1. Current Ratio Current Asset / Current 37857 / 50171 0.75

Liabilities
2. Net profit Margin Net Income / Net 21256 / 136835 15.53%

Revenue
3. Return on Equity Net Income / 21256 / 92463 22.99%

4. Earnings per Net Income / Total Share 21256 / 4199.86 5.06

5. Debt Ratio Total Debts / Total Assets 144608 / 379680 38.09%
11. Current Ratio:
The Current ratio of Verizon Communications Inc in 2022 is 0.75 times. This price
suggests that to pay $1 of current liabilities, Verizon Communications Inc has $0.75 of
current assets.
margin of 15.53% suggests that Verizon Communications Inc earned $15.53 profit from
every $1 of sales.
Verizon Communications Inc in 2022 is 22.99%. The ROE of 22.99% suggests that
Verizon Communications Inc shareholders have earned $22.99 of profit for every $100
they need to be invested within the company.
Verizon Communications Inc earns $5.06 per share of stock.
15. Debt Ratio:
debt of total assets. In 2022, the overall debt ratio is 38.09% suggests for every $100 of
assets, Verizon Communications Inc gains 38.09 takas from debt, and therefore the rest
$61.91 is returning from equity.

Verizon Communications Inc's qualitative investigation reveals a mixed performance. The
corporation has mild liquidity issues in satisfying short-term obligations with a current ratio of
0.75. The net profit margin of 15.53%, however, shows actual profitability. A return on equity
(ROE) of 22.9 percent indicates a positive financial outcome for owners. Strong profitability per
share is demonstrated by the $5.06 EPS. While the debt ratio of 38.09% suggests moderate
leverage, it will be essential to manage debt levels and increase the current ratio in order to
increase liquidity and keep a sound financial position. Maintaining a balance between
profitability, liquidity, and debt management will lead to long-term growth and increased value
for shareholders.
NYSE: AT&T Inc (T)

1. Current Ratio Current Asset / Current 33108 / 56173 0.59

Liabilities
2. Net profit Margin Net Income / Net -8524 / 120741 -12.70

Revenue %
3. Return on Equity Net Income / -8524 / 106457 -8.01%

4. Earnings per Net Income / Total Share -8524 / 7127.59 -1.19

5. Debt Ratio Total Debts / Total Assets 134570 / 402853 33.40%
16. Current Ratio:
The Current ratio of AT&T Inc Inc in 2022 is 0.59 times. This price suggests that to pay
$1 of current liabilities, AT&T Inc Inc has $0.59 of current assets.
The net profit Margin measures the net profit or loss from revenue. In 2022, a net loss
margin of 12.70% suggests that AT&T Inc incurred a $12.70 loss from every $1 of sales.
AT&T Inc in 2022 is negative 8.01%. The negative ROE of 8.01% suggests that AT&T
Inc shareholders have incurred $8.01 of loss for every $100 they need to be invested
within the company.
AT&T Inc incurred a loss of $-1.19 per share of stock.
20. Debt Ratio:
assets, AT&T Inc gains $33.40 from debt, and therefore the rest of $66.6 is returning
from equity.
AT&T Inc's qualitative study reveals a tough performance. The company's current ratio of 0.59
indicates serious liquidity issues, which could affect its capacity to pay short-term obligations.
With a loss of $12.70 for every $1 in sales, the net loss margin of 12.70% shows a negative
profitability. A bad return for shareholders is shown by a negative return on equity (ROE) of
8.01%, which represents a loss of $8.01 for every $100 invested. Earnings per share (EPS) of
-$1.19 represent a per-share loss. To regain financial stability and provide value for shareholders,
AT&T Inc. must address its liquidity concerns, boost profitability, and manage its debt well.
DSE – Telecommunication Industry (Overall Analysis):
(ROE) (EPS)
Grameenphone 0.13 20.01% 65.12% 22.29 22.18%
Ltd (GRAE)
Robi Axiata Ltd 0.20 2.12% 2.72% 0.35 23.85%

(ROBI)
Grameenphone Ltd (GRAE) scores better than Robi Axiata Ltd (ROBI) in a comparison of
financial ratios. Grameenphone Ltd. has a current ratio of 0.13, which is lower than Robi Axiata
Ltd.'s 0.20 and indicates greater liquidity. Furthermore, Grameenphone Ltd. has a net profit
margin of 20.01%, which is better than Robi Axiata Ltd.'s margin of 2.12%. Grameenphone Ltd
earns a return on equity (ROE) of 65.12%, while Robi Axiata Ltd records a ROE of 2.72%.
Furthermore, Robi Axiata Ltd has a lower earnings per share (EPS) of $0.35 than Grameenphone
Ltd, which has a larger EPS of $22.29. Grameenphone Ltd. and Robi Axiata Ltd. both have low
debt-to-equity ratios, at 22.18% and 23.85%, respectively. The overall financial performance of
Grameenphone Ltd is outstanding in terms of liquidity, profitability, ROE, and EPS.

NYSE – Telecommunication Industry (Overall Analysis):
(ROE) (EPS)
Verizon 0.75 15.53% 22.99% 5.06 38.09%
Communication
s Inc (VZ)
AT&T Inc (T) 0.59 -12.70 -8.01% -1.19 33.40%
%
Verizon Communications Inc (VZ) surpasses AT&T Inc (T) in key financial ratios. While AT&T
has a current ratio of 0.59, Verizon has a higher ratio of 0.75, indicating superior liquidity. In
comparison to AT&T, which has a negative margin of -12.70%, Verizon exhibits a better net profit
margin of 15.53%. Verizon has a substantially higher return on equity (ROE) than AT&T, with a
difference of 22.99% versus -8.01%. AT&T has a loss per share of $1.19 while Verizon posts
greater earnings per share (EPS) of $5.06. However, AT&T continues to have a lower debt ratio
than Verizon, at 33.40% as opposed to 38.09%. In comparison to AT&T Inc., Verizon
Communications Inc. performs better financially overall in terms of liquidity, profitability, ROE,
and EPS.
DSE: Bank Industry
IFIC Bank
No. Ratios Formula Calculation (BDT) Result
1 Current Current Asset / Current 8,027,132,753/4,877,962, 1.65

Ratio Liabilities 063
2 Net profit Net Income /Revenue 300,301,865/662,079,369 45.35%

Margin
3 Return on Net Income / 300,301,865/ 9.33%

Equity Shareholder’s Equity 3,217,904,443
(ROE)
4 Earnings Net Income / Total Share 3,442,365,075/1,785,910, 1.93

per Share Outstanding 939
(ESP)
5 Debt Ratio Total Debts / Total Assets 435,182,037,063/465,272, 93.53%

712,989
Current Ratio: A current ratio of 1.65 indicates that the company's current assets exceed its current liabilities
by 1.65 times. The company's liquidity is solid since it has enough current assets to fulfill its short-term
commitments. A current ratio greater than one is deemed positive since it implies the firm has adequate
support to cover its short-term commitments.
Net Profit Margin: A net profit margin of 45.35% indicates that 45.35 cents of every dollar of revenue is kept
as net profit. It implies that the firm is profitable in comparison to its revenue. A high net profit margin
suggests that a firm controls its costs and functions efficiently. It means that the firm has a solid price strategy,
reasonable expenditure control, and a competitive edge or distinctive market positioning.
Return on Equity: An ROE of 9.33% indicates that for every dollar of shareholder equity invested in the firm,
a profit of around 9.33 cents is generated. It elucidates the company's potential to make profits for its owners.
Earnings Per Share: An EPS of 1.93 indicates that the corporation earned $1.93 for each outstanding share of
stock. It denotes the part of the company's earnings allotted to each claim. EPS is a critical metric for investors
since it gives shareholders information about a company's profitability and prospective returns. stronger EPS
often signifies more robust profitability, and the firm generates more earnings per share.
Debt Ratio: A Debt Ratio of 93.53% indicates that debt finances around 93.53% of the company's total assets,
while equity finances the remaining 6.47%. It implies that the organization excessively relies on debt to
support its operations and expansion. A high debt-to-income ratio can have both beneficial and destructive
consequences. On the one hand, it might imply that the firm has been able to get extensive debt funding, which
could be advantageous for investment and expansion potential. On the other hand, a high Debt Ratio might
provide hazards and problems, such as increased interest expenditures, financial insecurity, and vulnerability to
economic downturns.
International Finance Investment and Commerce Bank Limited (IFIC Bank) is a limited liability banking
organization established in the People's Republic of Bangladesh. It was established in 1976 at the government's
request as a joint venture between sponsors in the private sector and the government of Bangladesh with the
dual goals of operating as a domestic finance firm and establishing joint venture banks and financial
institutions abroad. When the government permitted banks in the private sector in 1983, IFIC was transformed
into an entirely independent commercial bank. Currently, 32.75% of the Bank's share capital is owned by the
Government of the People's Republic of Bangladesh. 11.31% of the share capital is owned by directors and
sponsors with extensive business expertise, while the general public holds the remaining shares (IFIC Bank
PLC, n.d.). The Bangladesh Securities and Exchange Commission (BSEC) has granted the IFIC Bank PLC
permission to issue a 2.50% Stock Dividend for 2022 (Report, 2023). Over the last three months, IFIC has
been less volatile than 75% of BD stocks, generally moving +/- 0.1% weekly (IFIC Bank (DSE:IFIC) - Stock
Price, News & Analysis - Simply Wall St, 2023). The key data of the stock is P/E Ratio is 5.37, EPS is 2.09,
Market Capitalization is 20.50 billion, Shares Outstanding are 1.83 billion, Yield is 2.18%, Latest Dividend is
0.25, and Ex-Dividend Date is May 28, 23.
City Bank
N Ratios Formula Calculation (BDT) Result

o.
1 Current Ratio Current Asset / 4,242,171,567/1,741,1 2.44

Current Liabilities 89,535
2 Net profit Margin Net Income 4,507,766,687/ 21.09%

/Revenue 21373953000
3 Return on Equity (ROE) Net Income / 4,507,766,687/32,844, 13.72%

Shareholder’s 897,594
Equity
4 Earnings per Share (ESP) Net Income / Total 4,507,766,687/1,200,6 3.75

Share Outstanding 06,743
5 Debt Ratio Total Debts / Total 474,002,065,453/506, 93.52%

Assets 846,963,047
Current Ratio: A current ratio of 2.44 indicates that the company's current assets outnumber its current
liabilities by 2.44 times. It suggests the firm has a healthy liquidity situation since it has sufficient current
assets to meet its short-term obligations. A current ratio greater than one is deemed positive since it implies the
firm has adequate assets to cover its short-term commitments.
Net Profit Margin: A net profit margin of 21.09% implies that for every $1 of revenue, the firm generates,
around 21.09 cents is kept as net profit. It means the firm makes a profit of around 21.09% of its revenue. A
net profit margin of 21.09% is considered good since it implies that the firm appropriately manages its
expenses and creates a substantial profit margin.
Return on Equity: An ROE of 13.72% indicates that for every dollar of shareholder equity invested in the
firm, a profit of around 13.72 cents is generated. It elucidates the company's potential to make profits for its
owners. An ROE of 13.72% is considered excellent since it suggests the firm is earning a positive return on
shareholder capital. It implies that the firm is successfully employing its equity to produce profits.
stock. It indicates the part of the company's earnings allotted to each claim.
support its operations and expansion.
City Bank Limited changed the public's perception of it through its cutting-edge goods and services. However,
this bank was unable to escape default culture. Large categorized loans and advances again hampered the
bank's financial performance. The bank must lower its lending rate to increase demand for loans and advances.
It wasn't limited to loans and advances that were categorized. The bank's idle funds could have been used more
effectively. The unstable global economy, political unrest, the emergence of new rivals, etc., further contribute
to The City Bank Limited's deteriorating performance. City Bank Ltd, which has been operating in the nation
as a traditional bank since 1983, has been successful in solidifying its place in the industry. Through its better
services, contribution to the economy, and rise in shareholder value, the Bank has forged a strong presence
among its clients and the broader public(Performance Analysis of the City Bank Ltd, n.d.).
City Bank is one of the first private commercial banks to operate in Bangladesh. Having opened for business in
1983, it is one of the top five commercial banks in the nation. The Bank began its journey on March 27, 1983,
when it opened its first location at the B. B. Avenue Branch in the nation's capital, Dhaka. The founding and
growth of the bank were made possible by the innovative entrepreneurship of about 13 local businesses that
battled the enormous uncertainties and hazards with courage and devotion. When the voyage began, the
sponsor directors had just money and reserves totaling Taka 3.4 corer. Still, they now have a solid Taka 330.77
corer(Performance Analysis of the City Bank Ltd, n.d.). The bank operates 83 online branches nationwide,
including a fully functional Islami Banking branch. The bank is particularly active in alternate distribution in
addition to these conventional delivery places. It presently operates 25 ATMs on its own and 225 ATMs shared
with a partner bank, SMS Banking, Interest Banking, and other services. Its CustomerCallCenter will soon
begin operations. The bank intends to have 50 of its ATMs by the end of the current year(Performance
Analysis of the City Bank Ltd, n.d.). The City Bank Limited has built a solid reputation by offering
cutting-edge goods and services. Despite its many issues, it adheres to Bangladesh Bank guidelines and
regulations. Bangladesh Bank tightly supervises this bank.
NYSE: Bank Industry
U.S. Bancorp
No Ratios Formula Calculation ($) Result

.
1 Current Ratio Current Asset / 58933/562738 (in 0.10

Current Liabilities millions)
2 Net profit Margin Net Income 5838/22142(in 26.37%

/Revenue millions)
3 Return on Equity (ROE) Net Income / 5838/51232(in 11.40%

Shareholder’s millions)
Equity
4 Earnings per Share (ESP) Net Income / Total 5838/1530.98(in 3.81

Share Outstanding millions)
5 Debt Ratio Total Debts / Total 623573/ 674805(in 92.40%

Assets millions)
Current Ratio: A current ratio of 0.10 indicates that the company's current assets are only 0.10 times its
current liabilities. It signifies that the firm may struggle to satisfy its short-term obligations and experience a
liquidity crisis. A less than one current ratio is often seen as unfavorable, indicating that the firm lacks
sufficient current assets to satisfy its short-term commitments. It suggests that the firm relies excessively on
borrowed capital or is financially challenging.
Net Profit Margin: A net profit margin of 26.37% indicates that the firm retains around 26.37 cents for every
dollar of sales. It implies that the firm earns a profit of around 26.37% of its revenue. A net profit margin of
26.37% is considered good since it implies that the firm is effectively controlling its expenses and creating a
sizable profit margin.
owners. An ROE of 11.40% is acceptable since it implies that the firm is earning a good return on shareholder
capital.
stock. It denotes the part of the company's earnings allotted to each share.
support its operations and expansion.
The United States Bank of Oregon formed U.S. Bancorp as a holding company in the late 1960s, when many
significant banks throughout the country recognized and encouraged their metamorphosis into diversified
financial services businesses by founding bank holding companies. The company's historical roots, on the
other hand, go back nearly a century before the descriptive phrase 'diversified financial services organizations'
became part of banking nomenclature, to a simpler age when banking consisted of the rudimentary tasks of
receiving deposits, cashing checks, and extending and collecting loans(U.S. Bancorp - Company Profile,
Information, Business Description, History, Background Information on U.S. Bancorp, n.d.).
Based in Minneapolis, U.S. Bancorp is the country's 11th biggest financial services holding firm, with over
1,000 banking facilities in 16 Western and Midwest states. U.S. Bancorp is a prominent provider of corporate
trust services and the world's largest supplier of Visa corporate and buying cards. Consumers and companies
can also benefit from investing, payment systems, asset management, insurance, and banking services provided
by the corporation. Piper Jaffray, a subsidiary of US Bancorp, offers brokerage and investment banking
services through 100 branches(U.S. Bancorp - Company Profile, Information, Business Description, History,
Background Information on U.S. Bancorp, n.d.).
US Bancorp (USB) is a diversified financial services firm with subsidiaries that provide retail and commercial
banking, private banking, and wealth management solutions. Its product and service portfolio includes savings
and checking accounts, certificate of deposits, consumer and business loans, personal and business lines of
credit, mortgages, insurance, savings and investment products, brokerage and fund services, credit and debit
cards, asset and wealth management, and financial planning solutions. Leasing, international banking, payment
services, private banking, cash management, and online and mobile banking are also available from the
organization. It mostly works in the Midwest and West areas of the United States. USB is based in
Minneapolis, Minnesota, in the United States(ShieldSquare Captcha, n.d.).
During the quarter ending June 2019, institutional investors acquired a net $8.9 million in shares of USB,
giving them 77.30% of the total shares outstanding. This is a higher proportion than is normal for businesses in
the Major Banks category, indicating that the smart money regards this company as a valuable holding(USB -
US Bancorp Shareholders - CNNMoney.com, n.d.). Market Cap is 51.276B, Beta (5Y Monthly) is 0.96, PE
Ratio (TTM) is 8.94, and EPS (TTM) is 3.74.
Bank of America
1 Current Ratio Current Asset / Current 923502/2504509(in 0.36

Liabilities millions)
2 Net profit Margin Net Income /Revenue 27528/92407(in 29.79%

millions)
3 Return on Equity Net Income / 27528/273197 (in 10.07%

(ROE) Shareholder’s Equity millions)
4 Earnings per Share Net Income / Total Share 27528/7996.78(in 3.44

(ESP) Outstanding millions)
5 Debt Ratio Total Debts / Total Assets 2778178/3051375(in 91.05%

millions)
Current Ratio: A current ratio of 0.36 indicates that the company's current assets are only 0.36 times its
current liabilities. It signifies that the firm may struggle to satisfy its short-term obligations and experience a
liquidity crisis. A current ratio of less than one is often seen as negative, indicating that the firm lacks
sufficient current assets to satisfy its short-term commitments. It suggests that the firm relies excessively on
borrowed capital or is financially difficult.
Net Profit Margin: A net profit margin of 29.79% implies that for every $1 of revenue, the firm generates,
about 29.79 cents is kept as net profit. It implies that the firm earns a profit of around 29.79% of its revenue. A
net profit margin of 29.79% is deemed good since it implies that the firm is properly managing its expenses
and creating a substantial profit margin.
owners.
Earnings Per Share: An EPS of 3.44 indicates that the corporation earned $3.44 for every outstanding share
of stock. It indicates the fraction of the company's earnings assigned to each share.
Debt Ratio: A Debt Ratio of 91.05% indicates that about 91.05% of the company's total assets are funded by
debt, with the remaining 8.95% financed by equity. It implies that the corporation relies substantially on debt
to support its operations and expansion.
Bank of America's business has strong qualitative elements that provide them an advantage in the banking
sector. One qualitative component that offers Bank of America a competitive advantage over its competitors is
the value they provide to its clients. On consumer savings accounts, Bank of America provides a.03% APY.
Wells Fargo and Chase both provide only.01% APY on consumer savings accounts(Hicks, 2018). In fact, for
customers in the Preferred Rewards category, Bank of America will provide up to a.04% -.06% APY on
savings accounts. A hike in the Federal Funds Rate gives Bank of America a lift. The Federal Funds Rate is
currently set at 1.5%. According to Bankrate, the Federal Funds Rate was.75% just a year ago, which is half
the current rate(Hicks, 2018).
Bank of America is one of the world's major financial organizations, offering a comprehensive range of
banking, investing, asset management, and other financial and risk management products and services to
individuals, small and middle-market enterprises, and large corporations. The corporation supports about 56
million consumer and small business contacts in the United States. It is a global leader in corporate and
investment banking and trading and one of the world's major wealth management firms. Its Mkt cap is
232.62B, P/E ratio is 8.80, and Div yield is 3.01%. The stock of Bank of America has a consensus rating of
buy. The average rating is A1, with 35 buy ratings, 15 hold ratings, and 7 sell ratings(BAC Stock | News |
BANK OF AMERICA Stock Price Today | Analyst Opinions | Markets Insider, n.d.).
DSE /CSE – Bank Industry (Overall Analysis):
Current Net Profit Return on Earnings Debt Ratio

Ratio Margin Equity Per Share
(ROE) (EPS)
IFIC Bank 1.65 45.35% 9.33% 1.93 93.53%
City Bank 2.44 21.09% 13.72% 3.75 93.52%
City Bank has a higher current ratio than IFIC Bank which indicates that City Bank was more efficient in its
management of the assets. IFIC Bank has a higher net profit margin than City Bank, so more net income is
generated by IFIC Banks from their sale of goods. City Bank has a higher ROE which indicates that they are
more efficient at using shareholder’s equity to generate income, thus, increasing shareholders' wealth in 2022.
EPS of City Bank is more than IFIC Bank, this indicates City Banks’ performance and profitability are more
than IFIC Bank in 2022. In the case of the debt ratio, we can see that both of the banks have the same ratio
which means they are in a unstable position. IFIC Bank has made significant strides in its growth strategies.
NYSE – Bank Industry (Overall Analysis):
Current Net Profit Return on Earnings Debt Ratio

Ratio Margin Equity Per Share
(EPS)
U.S. 0.10 26.37% 11.40% 3.81 92.40%

Bancorp
Bank of 0.36 29.79% 10.07% 3.44 91.05%

America
Bank of America has a higher current ratio than U.S. Bancorp which indicates that Bank of America was more
efficient in their management of the assets. Bank of America has a higher net profit margin than U.S. Bancorp,
so more net income is generated by Bank of America from its sale of goods. U.S. Bancorp has a higher ROE
which indicates that they are more efficient at using shareholder’s equity to generate income, thus, increasing
shareholders' wealth in 2022. EPS of U.S. Bancorp is more than Bank of America, this indicates U.S.
Bancorp's performance and profitability is more than Bank of America's in 2022. Bank of America has lower
total debt – total asset ratio which indicates it is more stable than U.S. Bancorp. Bank of America management
is more effective overall and appears to be more reliable and adept at maximizing shareholder wealth in
contrast.
DSE: Food Industry
APEX FOOD LIMITED

(%)
1. PE Ratio Market price per share/ 181.90 / 5.14 35.39
EPS
2. Earnings per Net Income on common stocks/ 29,316,318/ 5,702,400 5.14
Share (EPS) Outstanding common stocks
3. Return on Equity Net Income on common stocks 29,316,318 / 719,540,884 4.07
(ROE) / Shareholder’s Equity
4. Book value Total equity/ Outstanding 66,838,000,000 /5,702,400 117.21
per share common stocks
5. Dividend Yield Dividend per share/ Market 2.00 / 181.90 1.1
Ratio price per share
1. PE Ratio: The PE ratio of a company measures its current share price relative to its earnings per share.
The PE ratio of Apex Food Ltd. Is 35.39%, which implies that the investors of this company are willing
to pay 35.39 taka for its 1 taka of current earnings. It also suggests that their investors can expect higher
earnings growth in the future.
2. Earnings Per Share (EPS): Earnings Per Share is determined as a company’s net income dividend by
the outstanding shares of its common stocks. The resulting number is used to determine a company’s
profitability. The higher the EPS value, the more profitable is the company. Apex Food Ltd. earned
5.14 taka per share of stock in 2022.
3. Return on Equity (ROE): Return on Equity (ROE) measures the profit of the shareholders. The Return
on equity of Apex Foods Ltd. in 2022 was 4.07%. It suggests that Apex Food’s shareholders have
earned 4.07 taka of profit from every 100 taka of shares invested within the company.
4. Book Value Per Share: It represents the minimum value of a company's equity and measures the book
value of a firm on a per-share basis. Apex Food Ltd.’s market value per share was 181.90 taka and its
book value per share was 117.21 taka in 2022. Since the market value is higher than its book value, it
indicates that that investors have a positive outlook on the company’s growth potential and future
earnings.
5. Dividend Yield Ratio: The dividend yield is an estimate of the dividend-only return of a stock
investment. This yield shows how much a company has paid out in dividends over the course of a year.
Apex Food Ltd. had dividend yield of 1.1%, which means the company paid annual dividends of $1.1
per share to its shareholders in 2022.
Apex food LTD established in 1979 also the subsidiary of Apex Group Co. It can be called public
limited company. They are already in stock market of DSE and CSE. The target is to possess the best
choice for accomplishing the customer’s fulfillment. Their quality policy is pursuing on the quality
acceptance of the matter improvement & Development for customers Fulfillment. Apex Food is an (A)
grade Company and also position is good in this Industry. Apex Food LTD is a winner of gold, silver &
bronze medals in the frozen food sector. The Bangladesh Securities and Exchange Commission has
asked 64 listed small- capitalized companies to raise their paid-up capital to at least Taka 30Cr. To
comply obligations and Apex food paid up capital by Taka 5.7 Cr. (NEWAGE article, June30, 2022).
Apex Foods was the Weeks top gainer, posting a 30.54% gain, while the new listed Union Insurance
was the worst loser shedding 16.49% after the recent abnormal price hike. (B. Barman. (2022).
Beximco pharma was the most traded stocks till then with shares worth Tk 66 million changing hands,
closely followed by Apex Foods, Associated oxygen, BD Lamps & National Feed Mills. Stocks see a
mix trend at the opening as Robi IPO hits in the market. (The Financial Express Online Report, 2020).
Apex Foods LTD was awarded the national export trophy many times and they are leading exporter of
frozen foods in fiscal year 12 and 14. They also recorded 16% growth in shrimp export in first half of
the current fiscal year, in the time country’s total shrimp export drop 10.42% during the same period.
This causes achieved expected growth. On 2020-21 fiscal year in the first half, the shrimp export
company stood at Taka 148.19 crore and also posted Taka 0.70 as earning per share (EPS) which was
7% more than the previous year. In this period, the country’s total shrimp export stood at Taka 165.32
Crore. Due to pandemic Covid 19, they couldn’t make a huge profit but still going on. The debt level is
low and not considered as risk and dividend is too low to be concern. Its long-term profitability &
Sustainability. Analysis of the various ratios for 2022 that shows some of them are suitable and some
others are not. Apex Foods accounting policies and estimates like those of the food industry are
sufficiently flexible.
BANGAS LIMITED

(%)
1. Market price per share/
PE Ratio 109.37/ 0.26 420.65
EPS
2. Earnings per Net Income on common stocks/
1,962,724/ 7,6246,43 0.26
3. Return on Equity Net Income on common stocks
1,962,724/ 159,177,003 1.23
(ROE) / Shareholder’s Equity
4. Book value Total equity/ Outstanding
159,200,000/ 7,6246,43 20.93
5. Dividend Yield Dividend per share/ Market
0.40 / 109.37 3.66
Ratio price per share
1. PE Ratio: P/E ratio of 420.65 indicates that the market has high expectations for the company's future
earnings growth. Such a high P/E ratio may suggest that investors anticipate strong performance and
profitability from Bangas Limited.
2. Earnings Per Share (EPS): The EPS of 0.26 suggests that the company's earnings per share are
relatively low. It would be important to investigate the reasons behind the low earnings and assess the
company's ability to improve profitability in the future.
3. Return on Equity (ROE): The ROE of 1.23% indicates that Bangas Limited's profitability in relation
to shareholders' equity is relatively low. This suggests that the company may not be generating
substantial returns for its shareholders.
4. Book Value Per Share: The BVPS of 20.93 indicates the net value of each share based on the
company's assets and liabilities. This information can be used to assess the company's valuation
compared to its market price and to evaluate the potential for future growth.
5. Dividend Yield Ratio: The dividend yield ratio of 3.66% indicates the proportion of dividend income
relative to the stock price. This suggests that the company pays out a portion of its earnings as
dividends to shareholders. It would be useful to analyze the company's dividend policy, stability, and
the potential for future dividend growth.
Bangas Limited manufactures and sells sweet and salted breads and biscuits under the Bangas brand name in
Bangladesh. The company also exports its products to India, Bhutan, Singapore, The United Arab Emirates,
Nigeria, Oman, Canada, The United States, The United Kingdom, and Australia. Bangas Limited was
incorporated in 1979 and is based in Dhaka, Bangladesh.
The Financial Statements of the Company are prepared on a going concern basis under historical cost
convention and in accordance with the International Accounting Standards (IASs) and International Financial
Reporting Standards (IFRSs), the Companies Act 1994, the Securities and Exchange Rules 1987 and other
applicable laws & regulation in Bangladesh. The company would offer a diverse range of food products
catering to the local market. This could include packaged food items, snacks, beverages, condiments, and
cooking essentials. The company might have its own production facilities equipped with modern machinery
and adhering to quality and safety standards. The manufacturing process would involve sourcing raw
materials, processing, packaging, and quality control measures. The company would establish a robust supply
chain network to procure raw materials from local farmers, suppliers, or importers. They would ensure the
availability of ingredients for production and maintain efficient logistics for timely distribution of products to
wholesalers, retailers, or directly to consumers. To build brand recognition and attract customers, the company
would engage in marketing and promotional activities. This may include advertising campaigns, product
packaging design, and strategic partnerships or collaborations. Companies operating in the food industry must
comply with relevant regulations, including food safety regulations, labeling requirements, and environmental
standards.
NYSE: FOOD INDUSTRY
Tyson Foods Inc.
(%)
1.
PE Ratio Market price per share/ EPS 50.39/ 8.99 5.61

3238/ 360 8.99
3. Return on Equity Net Income on common stocks /
3238/ 19811 16.34
19811/ 360 55.04
5. Dividend Yield Dividend per share/ Market price
3.5 / 50.39 6.94
Ratio per share
1. PE Ratio: with a P/E ratio of 5.61%, Tyson Foods appears to have a relatively low valuation compared
to its earnings per share (EPS). A low P/E ratio suggests that the market may have relatively modest
expectations for the company's future earnings growth or that the stock may be undervalued. (Low)
2. Earnings Per Share (EPS): The EPS of 8.99% indicates that Tyson Foods has generated solid
earnings per outstanding share. A higher EPS demonstrates the company's ability to generate profits
and distribute earnings to shareholders. (Healthy)
3. Return on Equity (ROE): Tyson Foods' ROE of 16.34% reflects the company's ability to generate
returns for its shareholders based on their invested equity. This indicates efficient utilization of
shareholders' funds to generate profits and create value. (Strong)
4. Book Value Per Share: The BVPS of 55.04% suggests that Tyson Foods' net assets exceed its
liabilities. As their book value per share ($55.04) is higher than the market value per share ($50.39),
their stock would be considered as undervalued.
5. Dividend Yield Ratio: The dividend yield ratio of 6.94% indicates the proportion of dividend income
relative to the stock price. A higher dividend yield can be appealing to income-seeking investors who
desire regular cash flow from their investments.
One of the biggest food firms in the world and a renowned expert on protein is Tyson Foods, Inc. John W.
Tyson founded the company in 1935, and four generations of his family have led it to success. The corporation,
which had its headquarters in Springdale, Arkansas has about 137,000 employees since about October 2, 2021.
Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp trusted excellence, Mexican original, and
State Fair are just a few of the many brands and products the company offers. The CEO declared that their
company has been based on religion, family, and hard work from the beginning. Tyson Foods is constantly
coming up with new ideas to improve the sustainability of protein, make food suitable for all conditions, and
change people's perceptions of what a good meal can accomplish. Every day, they uphold a rule known as the
5Cs. The consumer always comes first for them. They pay attention, assume good will, and then talk openly.
To improve every day, they welcome creativity. They succeed because they intentionally work together and are
inclusive. They commit every day to give results in the proper manner. On the New York Stock Exchange,
Tyson's stock is listed under the ticker TSN.
Beginning in fiscal 2022, they launched a new productivity program, which is designed to drive a better, faster
and more agile organization that is supported by a culture of continuous improvement and faster decision
making. They were targeting $1 billion in productivity savings by the end of fiscal 2024, including more than
$400 million in fiscal 2022, relative to a fiscal 2021 cost baseline. They realized more than $700 million of
productivity savings in fiscal 2022, which partially offset the impacts of inflationary market conditions, and we
now believe we will exceed our $1 billion target in fiscal 2023.
Flowers Foods Ltd.


(%)
1. PE Ratio Market price per share/ EPS 24.92/ 1.08 23.07
228,394/ 211,895 1.08
3. Return on Equity Net Income on common stocks /
228,394/ 3,312,994 6.89
3,312,994/ 211,895 15.64
5. Dividend Yield Dividend per share/ Market price per
0.87 / 24.92 3.49
Ratio share
1. PE Ratio: The PE ratio of 23.07% indicates that investors are willing to pay approximately 23 times
the earnings per share (EPS) for a share of Flower Foods. A high PE ratio suggests that the market has
high expectations for future growth or that the stock may be overvalued.
2. Earnings Per Share (EPS): With an EPS of 1.08%, Flower Foods generated $1.08 in earnings for each
outstanding share. EPS is a key measure of profitability and can be used to assess a company's ability
to generate earnings for its shareholders.
3. Return on Equity (ROE): Flower Foods' ROE of 6.89% indicates that for every dollar of
shareholders' equity, the company generated a return of 6.89%. ROE is a measure of a company's
profitability and efficiency in utilizing shareholders' investments.
4. Book Value Per Share: Flower Foods' BVPS of $15.64 represents the company's net assets per
outstanding share; whereas their market price per share is $24.94. This means, their market value is
higher than its book value, it indicates that that investors have a positive outlook on the company’s
growth potential and future earnings.
5. Dividend Yield Ratio: The dividend yield ratio of 3.49% indicates the percentage of the stock's price
that is returned to shareholders in the form of dividends. A higher dividend yield may attract
income-focused investors.
Flowers Foods, Inc is a producer and marketer of packed bakery food who’s headquartered is in Thomasville,
Georgia (FlowersFood,2022). The company runs 47 bakeries were bread, buns, rolls, snack cakes, pastries, and
tortillas are produced. The company was established in 1919, by the brothers William Howard and Joseph
Hampton Flowers opened Flowers baking company. In 1937, they bought the Tally Maid bakery, and in 1942,
they became the sixth bakery in the United States to franchise the Sunbeam brand and Little Miss Sunbeam for
its white bread. And after acquiring bakeries in Florida, Alabama, and Georgia in the middle to late 1960s, the
business changed its name to Flowers Industries in 1968, conducted an IPO, and started trading
over-the-counter. Flowers Food was listed on the American Stock Exchange just within a year. In fiscal year
2022, sales increased 11.0% to a record $4.806 billion, net income increased 10.8% to $228.4 million, adjusted
net income increased 3.0% to $271.0 million and adjusted EBITDA (1) increased 2.3% to $502.0 million,
representing 10.4% of sales, a 90-basis point decrease. Diluted EPS increased $0.10 to $1.07. Adjusted diluted
EPS (1) increased $0.03 to $1.27. Their top brands are Nature’s Own, Dave’s Killer Bread, Wonder, Canyon
Bake house, and Tasty-kake (Flowers Food, 2022). Flowers Foods have a straight forward mission statement in
which they state that their goal is to provide excellent baked goods that will delight people. They aspire to be a
visionary, forward-thinking baked goods company that places the customer at the center of everything. All of
their actions are based on the beliefs that they have maintained for more than a century (Flowers Food, 2022).
Currently Flowers Foods have 211.13M number of shares outstanding in the stock market. The current share
price per share is $28.75. Moreover, shares outstanding is 211.13M but public float shares of the company is
195.58M. The P/E Ratio of the company is 27.99, EPS is $1.03, Yield is 3.06%, and dividend per share is
$0.22 (Market Watch, 2022). Therefore, the company is operating efficiently in the stock market and holds a
good position in the stock market and has a promising future ahead.
DSE /CSE – Food Company (Overall Analysis):
Earnings Per Return on Book value per Dividend Yield

PE Ratio
Share (EPS) Equity (ROE) share Ratio
APEX FOODS LTD. 35.39 5.14 4.07 117.21 1.1
BANGAS LTD. 420.65 0.26 1.23 20.93 3.66
In this case, Bangas Ltd. has a significantly higher PE ratio than Apex Foods Ltd., indicating that investors are
willing to pay a much higher premium for Bangas Ltd.'s earnings compared to Apex Foods Ltd. EPS reflects a
company's profitability per share. Apex Foods Ltd. has a significantly higher EPS than Bangas Ltd., indicating
stronger earnings performance and potential profitability. ROE measures a company's ability to generate
profits from shareholders' equity. Apex Foods Ltd. has a higher ROE compared to Bangas Ltd., suggesting that
Apex Foods Ltd. is more efficient in utilizing shareholders' investments to generate returns. Book value per
share represents the net assets per outstanding share. Apex Foods Ltd. has a significantly higher book value per
share than Bangas Ltd., indicating a potentially stronger financial position. The dividend yield ratio represents
the percentage of the stock's price returned to shareholders in the form of dividends. Bangas Ltd. has a higher
dividend yield compared to Apex Foods Ltd., indicating a higher dividend payout relative to the stock price.
Overall, based on the provided data, Apex Foods Ltd. appears to have stronger financial indicators such as
higher EPS, ROE, book value per share, and a more reasonable PE ratio compared to Bangas Ltd. However,
qualitative research and a deeper analysis of both companies' qualitative factors, such as their competitive
positions, market trends, management team, and growth strategies, are essential to obtaining a more
comprehensive understanding of their overall performance and prospects.
NYSE – Food Inc. (Overall Analysis):
Earnings Per Return on Book value per Dividend Yield

PE Ratio
Share (EPS) Equity (ROE) share Ratio
TYSON FOOD INC. 5.61 8.99 16.34 55.04 6.94
FLOWERS FOOD
23.07 1.08 6.89 15.64 3.49
INC.
Tyson Foods Inc. has a significantly lower PE ratio compared to Flowers Foods Inc., suggesting that investors
are valuing Tyson Foods' earnings at a lower multiple. Tyson Foods Inc. has a higher EPS compared to
Flowers Foods Inc., indicating stronger earnings performance. Tyson Foods Inc. has a higher ROE compared
to Flowers Foods Inc., indicating that Tyson Foods Inc. is more efficient in utilizing shareholders' investments
to generate returns. Tyson Foods Inc. has a higher book value per share compared to Flowers Foods Inc.,
indicating a potentially stronger financial position. Tyson Foods Inc. has a higher dividend yield compared to
Flowers Foods Inc., indicating a higher dividend payout relative to the stock price. Based on these data, Tyson
Foods Inc. appears to have stronger financial indicators such as lower PE ratio, higher EPS, ROE, book value
per share, and a higher dividend yield compared to Flowers Foods Inc. However, it's important to conduct a
thorough qualitative analysis, considering factors such as the competitive position, market trends, management
team, growth strategies, and any recent news or developments of both companies to obtain a more
comprehensive understanding of their overall performance and prospects.
Rankings – DSE / CSE
1. Grameenphone
2. Square
3. Beximco
4. Robi
5. City Bank
6. IFIC Bank
7. Apex Food Ltd
8. Fine Food Ltd
Current Ratio Net Profit ROE EPS Debt ratio

Margin
GP 0.13 20.01% 65.12% 22.29 22.18%
Square 17.3 32% 18% 20.51 5.94%
Beximco 1.45 15% 11% 11.48 33%
Robi 0.20 2.12% 2.72% 0.35 23.85%
City bank 2.44 21.09% 13.72% 3.75 93.52%
IFIC bank 1.65 45.35% 9.33% 1.93 93.53%
Apex Food 1.46 0.43% 1.73% 2.07 53.18%
Fine Food 12.04 2.66% 1.06% .11 5.21%
The Return on Equity and Earnings Per Share (EPS) of Grameenphone is much higher than
other industries. But Robi’s EPS is not that high so Grameenphone has the best performance over
the course of the year and has put in place growth and new market entry initiatives that will
improve stock performance in the future. Similar steps have been made for future growth by
Square and Beximco Pharmaceuticals, however, Square’s EPS was Close to GP but their ROE is
less. City and IFIC banks have a huge % of debt ratio. The food industry Eps is less compared to
the Pharmaceuticals and Telco industries.

Rankings – NYSE
Current Net profit Return on Debt

Ratios Margin Equity Earnings Ratio
(ROE) Per
Share
(EPS)
1.35 22% 28%

Johnson & 7.94 59%
Johnson
1.22 31% 33%

Pfizer Inc. 5.59 51%
Verizon 0.75 15.53% 22.99 5.06 38.09%

Communicati %
ons Inc (VZ)
AT&T Inc (T) 0.59 -12.70% -8.01 -1.19 33.40%

%
U.S. Bancorp 0.10 26.37% 11.40% 3.81 92.40%
Bank of 0.36 29.79% 10.07% 3.44 91.05%

America
Tyson Food 1.55 6.48% 17.06% 8.34 50.82%
Inc.
Flowers Food 1.44 4.76% 14.60% 0.97 56.62%
Inc.
Pfizer controls their overall costs more effectively than the other three corporations because they have the
eight's most significant net profit margin. Additionally, the higher return on equity suggests that Pfizer is more
profitable and that their revenues are produced more effectively.
As per Eps, the ranking would be
1. Tyson Food Inc.
2. Johnson & Johnson Pharmaceuticals.
3. Pfizer Inc.
4. Verizon Communications Inc (VZ).
5. U.S. Bancorp.
6. Bank of America.
7. Flowers Food Inc.
8. AT&T Inc (T).
Reference:
BAC Stock | News | BANK OF AMERICA Stock Price Today | Analyst Opinions | Markets Insider.
(n.d.). markets.businessinsider.com.
https://markets.businessinsider.com/stocks/bac-stock#:~:text=Bank%20of%20America%20stock%20ha
s,ratings%2C%20and%207%20sell%20ratings.
Hicks, D. (2018, January 25). Bank Of America’s Value: Quantitative And Qualitative. Seeking Alpha.
https://seekingalpha.com/article/4140183-bank-of-americas-value-quantitative-and-qualitative
IFIC Bank PLC. (n.d.).
https://www.ificbank.com.bd/details-of-business#:~:text=At%20IFIC%2C%20we%20want%20to,class
%20value%20to%20all%20stakeholders.
IFIC Bank (DSE:IFIC) - Stock Price, News & Analysis - Simply Wall St. (2023, June 19). Simply Wall
St. https://simplywall.st/stocks/bd/banks/dse-ific/ific-bank-shares
Performance Analysis of the City Bank Ltd. (n.d.). Assignment Point.
https://assignmentpoint.com/performance-analysis-city-bank-ltd/
Report, T. (2023, May 21). IFIC Bank gets BSEC consent to issue 2.5% stock dividend. The Business
Standard.
https://www.tbsnews.net/economy/stocks/ific-bank-gets-bsec-consent-issue-25-stock-dividend-635362
ShieldSquare Captcha. (n.d.).
https://www.globaldata.com/company-profile/us-bancorp/#:~:text=U.S.%20Bancorp%20(USB)%20is
%20a,management%20solutions%20through%20its%20subsidiaries.
USB - US Bancorp Shareholders - CNNMoney.com. (n.d.).
https://money.cnn.com/quote/shareholders/shareholders.html?symb=USB&subView=institutional
U.S. Bancorp - Company Profile, Information, Business Description, History, Background Information
on U.S. Bancorp. (n.d.). https://www.referenceforbusiness.com/history2/33/U-S-Bancorp.html

Appendix:

FIN433 - Group Report

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

FIN433 - Group Report

Uploaded by

Copyright:

Available Formats

Fin 433- Section: 1

Md. Nowroz Zaman 2021856630

Rifat-ul Islam 2012796630

Sanjida Shahabuddin 2012432630

Jannatul Ferdousi Prity 1911654630

20th June 2022

Subject: A Project of Quantitative & Qualitative Research Analysis on Different Companies

BANGLADESH – DSE/ CSE.............................................................................

BEXIMCO PHARMACEITICALS LTD................................................

SQUARE PHARMACEUTICALS LTD.....................................................

Robi Axiata Ltd

APEX FOODS LTD...................................................................................

NEW YORK STOCK EXCHANGE (NYSE)...................................................

JOHNSON & JOHNSON PHARMACEITICALS COMPANY...........

PFIZER INC. PHARMACEITICALS COMPANY................................

FLOWER FOOD COMPANY...................................................................

TYSON FOOD COMPANY.......................................................................

Verizon Communications Inc

DSE/CSE – FOOD INDUSTRY..........................................................................

NYSE – FOOD INDUSTRY................................................................................

BEXIMCO PHARMACEUTICALS LTD

No. Ratios Formula Calculation Result

1. Current Ratio Current Asset / Current 18419.26 / 12735.93 1.45

2. Net profit Margin Net Income / Net 5123.14 / 34669.17 15%

3. Return on Equity Net Income / 5123.14 /44636 11%

4. Earnings per Net Income / Total Share 5123.14 /446.11 11.48

5. Debt Ratio Total Debts / Total Assets 21512.03 / 66148.04 33%

Net profit Margin:

Return on Equity (ROE):

Earnings per Share (ESP):

Beximco Pharmaceuticals, established in 1980, and the largest pharmaceutical company in

No. Ratios Formula Calculation Result

1. Current Ratio Current Asset / Current 62347.73 / 3661.83 17.03

3. Return on Equity Net Income / 18176.77 / 103453.45 18%

4. Earnings per Net Income / Total Share 18176.77 / 886.45 20.51

5. Debt Ratio Total Debts / Total Assets 6535.28 / 109988.73 5.94%

Net profit Margin:

Return on Equity (ROE):

Earnings per Share (ESP):

Johnson & Johnson Pharmaceuticals

No. Ratios Formula Calculation ($) Result

1. Current Ratio Current Asset / 60979 / 45226 1.35

3. Return on Equity Net Income / 20878 / 74023 28%

5. Debt Ratio Total Debts / Total Assets 107995 / 182018 59%

2. Net profit Margin:

4. Earnings per Share (ESP):

Earnings per Share (ESP) is determined as a company’s income dividend by the

Johnson & Johnson earns 7.94 per share of stock.

capitalization of more than

(ESP) is calculated by dividing a company's income dividend by the number of outstanding

total debt and total assets

No. Ratios Formula Calculation ($) Result

1. Current Ratio Current Asset / 51259 / 42138 1.22

3. Return on Equity Net Income / 31372/ 95917 33%

5. Debt Ratio Total Debts / Total 101288 / 197205 51%

2. Return on Equity (ROE):

Earnings per Share (ESP) is determined as a company’s income dividend by the

Pfizer earns 5.54 per share of stock.

calculated by dividing a company's income dividend by the number of outstanding

invest in the business.Earnings per Share (ESP) is calculated by dividing a company's

leverage is measured by a debt ratio.

income is generated by Beximco Pharmaceuticals from their sale of goods. Square

introduce COVID reactionary drugs through the production of Paxlovid Pills.

Current Net profit Return on Earnings Debt